This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Author information
Author notes
Nick Arvanitidis recently retired from Liposome Technology after 14 years as its chief executive officer.
- Nick Arvanitidis
Rights and permissions
About this article
Cite this article
Arvanitidis, N. Are CEOs the biggest obstacle to consolidation?. Nat Biotechnol 13, 731 (1995). https://doi.org/10.1038/nbt0895-731
Issue date:
DOI: https://doi.org/10.1038/nbt0895-731